
A Diverse and Inclusive Team: Celebrating Differences at Scailyte
Highlighting Our Commitment to Diversity and Inclusion
🌍 At Scailyte, we take great pride in our commitment to Environmental, Social, and Governance (ESG) principles. Today, we want to highlight our strong focus on Diversity and Inclusion, particularly in terms of nationality and gender pay. 🌈🤝
With a team of 22 people, we have fostered a diverse and inclusive environment where everyone’s unique backgrounds and perspectives are celebrated. We firmly believe that diversity fuels innovation and drives success. 💡🚀
Gender diversity is a top priority for us, and we are proud to say that 50% of our full team consists of talented and inspiring women. But it doesn’t stop there—when it comes to leadership positions, 2 of the 3 C-level positions are held by exceptional women. 💼👩💼
Our diversity extends beyond gender. We are a team comprised of individuals from various nationalities, representing the rich tapestry of cultures around the globe. 🌎✨ Here is a snapshot of the nationalities that make up our Scailyte family:
🇧🇬 Bulgaria
🇨🇭 Switzerland
🇺🇸 USA
🇫🇷 France
🇮🇹 Italy
🇵🇹 Portugal
🇵🇱 Poland
🇩🇪 Germany
🇵🇰 Pakistan
🇮🇳 India
🇧🇩 Bangladesh
🏴 Wales
🇳🇿 New Zealand
🇭🇷 Croatia
By embracing such a diverse range of backgrounds, experiences, and perspectives, we foster an inclusive environment that values and respects everyone’s contributions. Together, we push the boundaries of innovation and create groundbreaking solutions for the future. 💪💫
At Scailyte, we firmly believe that true success is achieved through the collective power of a diverse and inclusive workforce. We remain committed to nurturing a culture that promotes equality, fosters innovation, and empowers every individual to thrive. 🌟🤝
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
Transforming Healthcare with Unmatched Biomarker Discovery Power
Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...
Recent News
LSX Congress USA 2023
Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...
Recent News
Unveiling ScaiVision's Clinical Potential
Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...
Recent News
ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier
In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...
Recent News
Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform
Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...
Recent News
Empowering Precision Healthcare with Unparalleled Discovery Potential
From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...
Recent News
Accelerating Discoveries with Scailyte's Speed Strength
In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...
Recent News
Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth
At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...
Recent News
Transforming Healthcare with Unmatched Biomarker Discovery Power
Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...
LSX Congress USA 2023
Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...
Recent News
Unveiling ScaiVision's Clinical Potential
Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...
ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier
In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...
Recent News
Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform
Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...
Empowering Precision Healthcare with Unparalleled Discovery Potential
From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...
Recent News
Accelerating Discoveries with Scailyte's Speed Strength
In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...
Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth
At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...